These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34202636)

  • 21. Shenqi fuzheng injection improves cvb3-induced myocarditis via inhibiting traf6 expression.
    Chen J; Wang Z; Wu T
    Cell Mol Biol (Noisy-le-grand); 2013 Feb; 59 Suppl():OL1826-34. PubMed ID: 23374452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crocetin Exerts a Cardio-protective Effect on Mice with Coxsackievirus B3-induced Acute Viral Myocarditis.
    Qin L; Liu H; Wang J; Wang W; Zhang L
    J Oleo Sci; 2021; 70(8):1115-1124. PubMed ID: 34349088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice.
    Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X
    Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
    Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
    J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
    Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
    Müller I; Pappritz K; Savvatis K; Puhl K; Dong F; El-Shafeey M; Hamdani N; Hamann I; Noutsias M; Infante-Duarte C; Linke WA; Van Linthout S; Tschöpe C
    PLoS One; 2017; 12(8):e0182643. PubMed ID: 28800592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The comparison of α-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms.
    Zhang Y; Cao W; Xie YH; Yang Q; Li XQ; Liu XX; Wang SW
    Int Immunopharmacol; 2012 Sep; 14(1):107-13. PubMed ID: 22709476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
    Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
    Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual roles of calpain in facilitating Coxsackievirus B3 replication and prompting inflammation in acute myocarditis.
    Li M; Su Y; Yu Y; Yu Y; Wang X; Zou Y; Ge J; Chen R
    Int J Cardiol; 2016 Oct; 221():1123-31. PubMed ID: 27472894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
    Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
    Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.
    Van Linthout S; Savvatis K; Miteva K; Peng J; Ringe J; Warstat K; Schmidt-Lucke C; Sittinger M; Schultheiss HP; Tschöpe C
    Eur Heart J; 2011 Sep; 32(17):2168-78. PubMed ID: 21183501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
    Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
    Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial injury occurs earlier than myocardial inflammation in acute experimental viral myocarditis.
    Lim BK; Shin JO; Choe SC; Choi SW; Jeong JO; Seong IW; Kim DK; Jeon ES
    Exp Mol Med; 2005 Feb; 37(1):51-7. PubMed ID: 15761252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.
    Malz R; Weithauser A; Tschöpe C; Schultheiss HP; Rauch U
    Cardiovasc Ther; 2014 Jun; 32(3):113-9. PubMed ID: 24533719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.